Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.229ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.229ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.415EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.415EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.415ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.415EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.415EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.415ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.415ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.23.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.23.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.23.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.23.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.23.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.64EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.64ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.64ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.64EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.64EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.68EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.68ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.68ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.68EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.68EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.65 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.65 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.65 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.65 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.65 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.65 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.65 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.65 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used